Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Titles
NEW
 Top 50 Non-Healthcare Titles
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Addictions Therapeutics Global Market Report 2025
Request Sample Buy Now
Global Addictions Therapeutics Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Addictions Therapeutics Global Market Report 2025

By Drug Type (Buprenorphine, Naltrexone, Bupropion, Disulfiram, Nicotine Replacement Products, Varenicline, Other Drugs), By Treatment Type (Opioid Addiction Treatment, Alcohol Addiction Treatment, Nicotine Addiction Treatment, Other Substance Addiction Treatment), By Treatment Center (Inpatient Treatment Center, Residential Treatment Center, Outpatient Treatment Center), By Distribution Channel (Hospital Pharmacies, Medical Stores, Other Distribution Channel), By Application (Public, Private, Government ) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Addictions Therapeutics Market Overview

• Addictions Therapeutics market size has reached to $7.05 billion in 2024

• Expected to grow to $9.57 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%

• Growth Driver: Rising Alcohol Consumption Drives Growth In The Addiction Therapeutics Market

• Market Trend: Innovative Breakthroughs In Addiction Therapeutics Market

• North America was the largest region in 2024.

What Is Covered Under Addictions Therapeutics Market?

Addiction therapeutics refers to medication, treatment, and management of various forms of addiction to help individuals overcome substance use disorders (SUDs) and other forms of addiction. It involves group and individual therapy sessions to prevent substance misuse.

The main addiction therapeutics include buprenorphine, naltrexone, bupropion, disulfiram, nicotine replacement products, varenicline, and others. Buprenorphine refers to a semi-synthetic narcotic analgesic that is given as C29H41NO4HCl as a dosage form and it is used to mimic the effects of opioid medicines to prevent withdrawal symptoms when an individual stops using them. The various treatment types are opioid addiction treatment, alcohol addiction treatment, nicotine addiction treatment, and other substance addiction treatment that are used in various treatment centers such as inpatient treatment centers, residential treatment centers, and outpatient treatment centers. These are distributed via different distribution channels such as hospital pharmacies, medical stores, and others that are applied in public, private, and government.

Addictions Therapeutics Market Size and growth rate 2025 to 2029: Graph

What Is The Addictions Therapeutics Market Size 2025 And Growth Rate?

The addictions therapeutics market size has grown strongly in recent years. It will grow from $7.05 billion in 2024 to $7.46 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increased use of addictive substances such as alcohol, tobacco, and drugs, rising awareness and escalating prevalence of substance abuse disorders, legalization of marijuana in various states, increased funding and support for addiction treatment initiatives

What Is The Addictions Therapeutics Market Growth Forecast?

The addictions therapeutics market size is expected to see strong growth in the next few years. It will grow to $9.57 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to rising drug awareness campaigns, emergence of synthetic drugs and new psychoactive substances, changing lifestyles and stress factors, expanding rehabilitation facilities, integration of telehealth services in addiction treatment. Major trends in the forecast period include technological advancements in diagnostics, neuroscientific advances, partnerships and collaborations between pharmaceutical companies and other stakeholders to address addiction issues, innovative drug launch for addictions therapeutics.

The forecast of 6.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of medication-assisted treatment (MAT) by inflating prices of buprenorphine-naloxone formulations and long-acting injectables developed in Canada and the UK, resulting in delayed recovery timelines and higher addiction medicine costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Addictions Therapeutics Market Segmented?

1) By Drug Type: Buprenorphine, Naltrexone, Bupropion, Disulfiram, Nicotine Replacement Products, Varenicline, Other Drugs

2) By Treatment Type: Opioid Addiction Treatment, Alcohol Addiction Treatment, Nicotine Addiction Treatment, Other Substance Addiction Treatment

3) By Treatment Center: Inpatient Treatment Center, Residential Treatment Center, Outpatient Treatment Center

4) By Distribution Channel: Hospital Pharmacies, Medical Stores, Other Distribution Channel

5) By Application: Public, Private, Government

Subsegments:

1) By Buprenorphine: Subutex, Suboxone

2) By Naltrexone: Oral Naltrexone, Extended-Release Naltrexone (Vivitrol)

3) By Bupropion: Wellbutrin, Zyban

4) By Disulfiram: Antabuse

5) By Nicotine Replacement Products: Nicotine Patches, Nicotine Gum, Nicotine Inhalers, Nicotine Lozenges

6) By Varenicline: Chantix (Champix)

7) By Other Drugs: Acamprosate, Topiramate, Gabapentin

What Is Driving The Addictions Therapeutics Market? Rising Alcohol Consumption Drives Growth In The Addiction Therapeutics Market

Increasing consumption of alcohol is expected to propel the growth of the addiction therapeutics market going forward. Alcohol consumption refers to the process of drinking beverages containing ethyl alcohol. Addiction therapeutics are used to treat addiction concerning alcohol that encourage individuals to consume less alcohol by preventing the depressive effects of alcohol and promoting the balance between the excitatory and inhibitory neurotransmitters glutamate and gamma-aminobutyric acid in an individual that reduces alcohol cravings and alleviates symptoms and suppresses symptoms such as insomnia, anxiety, and restlessness reading alcohol withdrawal. For instance, in February 2023, according to a report published by Statistics Canada, a Canada-based national statistical agency, alcoholic beverage sales at retail establishments and liquor authorities totaled $26.1 billion in the fiscal year ending on March 31, 2022, marking a 2.4% uptick from the previous year. Wine sales saw a 2.1% increase, reaching $8.1 billion in the same period. In terms of the overall composition, beer constituted 34.9% of the total alcohol sales value in 2021–2022, trailed by wine at 31.3%, spirits at 25.8%, and ciders and coolers at 8.0%. Therefore, increasing consumption of alcohol is propelling the addiction therapeutics market.

What Is Driving The Addictions Therapeutics Market? The Impact Of Rising Global Healthcare Expenditure On The Addiction Therapeutics Market

The growing healthcare expenditure is expected to boost the growth of the addiction therapeutics market going forward. Healthcare expenditure refers to the total amount of financial resources spent by individuals, communities, or governments on healthcare-related goods and services within a specified period. Globally increasing healthcare expenditure spurs the expansion of the addiction therapeutics market, promoting advanced treatment accessibility, fostering research and development, facilitating innovative therapy adoption, and enhancing comprehensive healthcare services for substance use disorders. For instance, in March 2022, according to the 2021–2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services, a US-based federal agency, the projected growth indicates that, on average, national health spending is expected to increase by 5.1% annually between 2021 and 2030, reaching a total of nearly $6.8 trillion. Additionally, it is anticipated that from 2021 to 2030, Medicare spending is going to rise at a 7.2% annual pace while Medicaid spending will rise at a 5.6% annual rate. Therefore, the growing healthcare expenditure is driving the growth of the addiction therapeutics market.

Who Are The Major Players In The Global Addictions Therapeutics Market?

Major companies operating in the addictions therapeutics market include Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Perrigo Company plc, Purdue Pharma L.P., Dr. Reddy's Laboratories Ltd., Cipla Inc., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Mallinckrodt Plc, Alkermes plc., Glenmark Pharmaceuticals Limited, Indivior plc., Lannett Company Inc., BioDelivery Sciences International Inc., Insys Therapeutics Inc., Camurus AB, Orexo AB, Elite Pharmaceuticals Inc., Braeburn Inc., Titan Pharmaceuticals Inc., BioCorRx Inc.

What Are The Key Trends Of The Global Addictions Therapeutics Market? Innovative Breakthroughs In Addiction Therapeutics Market

Major companies operating in the addiction therapeutics market are developing innovative products such as drugs for cocaine use disorders (CUD) to meet larger customer bases, more sales, and increase revenue. Drugs for cocaine use disorders (CUD) are medications designed to help individuals who are struggling with cocaine addiction or dependence. For instance, in January 2023, Tempero Bio, a US-based biopharmaceutical company, announced the U.S. Food and Drug Administration (FDA) approval for the TMP-301. The distinguishing characteristic of TMP-301, the Company's investigational candidate, lies in its role as a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM). Specifically tailored for a prominent role in treating cocaine use disorders (CUD), TMP-301 stands out for its potency, selectivity, and oral availability, all aimed at effectively curbing the overactive glutamate signaling associated with CUD.

What Are The Key Trends Of The Global Addictions Therapeutics Market? Advancements In Addiction Therapeutics Market Propelled By Strategic Partnerships

Major companies operating in the addiction therapeutics market are adopting a strategic partnership approach to treat nicotine addiction via smartphones. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in January 2022, Pfizer Inc., a US-based pharmaceutical and biotechnology company, partnered with Alex Therapeutics, a Sweden-based digital therapeutics company. The primary emphasis of this partnership is on a digital therapeutic designed to address nicotine addiction through smartphone intervention. Developed by Alex Therapeutics and tailored to meet the specifications of the German healthcare system in conjunction with Pfizer Germany, the medical device serves as the focal point of the partnership. Leveraging Alex Therapeutics' AI-driven digital therapeutics platform, known as the Alex DTx Platform, the collaboration integrates evidence-based psychological approaches, notably Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT), with artificial intelligence. The platform offers personalized standalone treatments, aiming to fulfill unmet needs among patients on a global scale.

Need data on a specific region in this market?
Request Customisation

Addictions Therapeutics Market Merger And Acquisition: Indivior Enhances Addiction Treatment Portfolio With Acquisition Of Opiant Pharmaceuticals Inc.

In March 2023, Indivior, a US-based pharmaceutical company, acquired Opiant Pharmaceuticals Inc for approximately $145 million. With this acquisition, Indivior aims to strengthen its portfolio in investigational opioid overdose therapy and boost its scientific research and addiction treatment portfolio. Opiant Pharmaceuticals Inc. is a US-based biopharmaceutical company offering medicines for addiction and drug overdose.

Regional Outlook For The Global Addictions Therapeutics Market

North America was the largest region in the addictions therapeutics market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Addictions Therapeutics Market?

The addiction therapeutics market consists of revenues earned by entities by providing cognitive behavioral therapy, contingency management for addiction, rational emotive behavior therapy (REBT), motivational interviewing, family therapy for addiction, facilitation therapy for addiction, eye movement desensitization and reprocessing (EMDR), dialectical behavior therapy, matrix model for addiction and person-centered therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The addiction therapeutics market also includes sales of suboxone, methadone, naltrexone, antidepressants, and acamprosate. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Addictions Therapeutics Industry?

The addictions therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the addictions therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Addictions Therapeutics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $7.46 billion
Revenue Forecast In 2034 $9.57 billion
Growth Rate CAGR of 6.4% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Type: Buprenorphine, Naltrexone, Bupropion, Disulfiram, Nicotine Replacement Products, Varenicline, Other Drugs
2) By Treatment Type: Opioid Addiction Treatment, Alcohol Addiction Treatment, Nicotine Addiction Treatment, Other Substance Addiction Treatment
3) By Treatment Center: Inpatient Treatment Center, Residential Treatment Center, Outpatient Treatment Center
4) By Distribution Channel: Hospital Pharmacies, Medical Stores, Other Distribution Channel
5) By Application: Public, Private, Government Subsegments: 1) By Buprenorphine: Subutex, Suboxone
2) By Naltrexone: Oral Naltrexone, Extended-Release Naltrexone (Vivitrol)
3) By Bupropion: Wellbutrin, Zyban
4) By Disulfiram: Antabuse
5) By Nicotine Replacement Products: Nicotine Patches, Nicotine Gum, Nicotine Inhalers, Nicotine Lozenges 6) By Varenicline: Chantix (Champix) 7) By Other Drugs: Acamprosate, Topiramate, Gabapentin
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Perrigo Company plc, Purdue Pharma L.P., Dr. Reddy's Laboratories Ltd., Cipla Inc., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Mallinckrodt Plc, Alkermes plc., Glenmark Pharmaceuticals Limited, Indivior plc., Lannett Company Inc., BioDelivery Sciences International Inc., Insys Therapeutics Inc., Camurus AB, Orexo AB, Elite Pharmaceuticals Inc., Braeburn Inc., Titan Pharmaceuticals Inc., BioCorRx Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Addictions Therapeutics Market Characteristics

3. Addictions Therapeutics Market Trends And Strategies

4. Addictions Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Addictions Therapeutics Growth Analysis And Strategic Analysis Framework

5.1. Global Addictions Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Addictions Therapeutics Market Growth Rate Analysis

5.4. Global Addictions Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Addictions Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Addictions Therapeutics Total Addressable Market (TAM)

6. Addictions Therapeutics Market Segmentation

6.1. Global Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Buprenorphine

Naltrexone

Bupropion

Disulfiram

Nicotine Replacement Products

Varenicline

Other Drugs

6.2. Global Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Opioid Addiction Treatment

Alcohol Addiction Treatment

Nicotine Addiction Treatment

Other Substance Addiction Treatment

6.3. Global Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Inpatient Treatment Center

Residential Treatment Center

Outpatient Treatment Center

6.4. Global Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Medical Stores

Other Distribution Channel

6.5. Global Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Public

Private

Government

6.6. Global Addictions Therapeutics Market, Sub-Segmentation Of Buprenorphine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Subutex

Suboxone

6.7. Global Addictions Therapeutics Market, Sub-Segmentation Of Naltrexone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Naltrexone

Extended-Release Naltrexone (Vivitrol)

6.8. Global Addictions Therapeutics Market, Sub-Segmentation Of Bupropion, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Wellbutrin

Zyban

6.9. Global Addictions Therapeutics Market, Sub-Segmentation Of Disulfiram, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antabuse

6.10. Global Addictions Therapeutics Market, Sub-Segmentation Of Nicotine Replacement Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Nicotine Patches

Nicotine Gum

Nicotine Inhalers

Nicotine Lozenges

6.11. Global Addictions Therapeutics Market, Sub-Segmentation Of Varenicline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chantix (Champix)

6.12. Global Addictions Therapeutics Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acamprosate

Topiramate

Gabapentin

7. Addictions Therapeutics Market Regional And Country Analysis

7.1. Global Addictions Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Addictions Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Addictions Therapeutics Market

8.1. Asia-Pacific Addictions Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Addictions Therapeutics Market

9.1. China Addictions Therapeutics Market Overview

9.2. China Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Addictions Therapeutics Market

10.1. India Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Addictions Therapeutics Market

11.1. Japan Addictions Therapeutics Market Overview

11.2. Japan Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Addictions Therapeutics Market

12.1. Australia Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Addictions Therapeutics Market

13.1. Indonesia Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Addictions Therapeutics Market

14.1. South Korea Addictions Therapeutics Market Overview

14.2. South Korea Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Addictions Therapeutics Market

15.1. Western Europe Addictions Therapeutics Market Overview

15.2. Western Europe Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Addictions Therapeutics Market

16.1. UK Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Addictions Therapeutics Market

17.1. Germany Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Addictions Therapeutics Market

18.1. France Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Addictions Therapeutics Market

19.1. Italy Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Addictions Therapeutics Market

20.1. Spain Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Addictions Therapeutics Market

21.1. Eastern Europe Addictions Therapeutics Market Overview

21.2. Eastern Europe Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Addictions Therapeutics Market

22.1. Russia Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Addictions Therapeutics Market

23.1. North America Addictions Therapeutics Market Overview

23.2. North America Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Addictions Therapeutics Market

24.1. USA Addictions Therapeutics Market Overview

24.2. USA Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Addictions Therapeutics Market

25.1. Canada Addictions Therapeutics Market Overview

25.2. Canada Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Addictions Therapeutics Market

26.1. South America Addictions Therapeutics Market Overview

26.2. South America Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Addictions Therapeutics Market

27.1. Brazil Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Addictions Therapeutics Market

28.1. Middle East Addictions Therapeutics Market Overview

28.2. Middle East Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Addictions Therapeutics Market

29.1. Africa Addictions Therapeutics Market Overview

29.2. Africa Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Addictions Therapeutics Market Competitive Landscape And Company Profiles

30.1. Addictions Therapeutics Market Competitive Landscape

30.2. Addictions Therapeutics Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Mylan N.V. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Addictions Therapeutics Market Other Major And Innovative Companies

31.1. Sun Pharmaceutical Industries Limited

31.2. Perrigo Company plc

31.3. Purdue Pharma L.P.

31.4. Dr. Reddy's Laboratories Ltd.

31.5. Cipla Inc.

31.6. Hikma Pharmaceuticals plc

31.7. Amneal Pharmaceuticals Inc.

31.8. Mallinckrodt Plc

31.9. Alkermes plc.

31.10. Glenmark Pharmaceuticals Limited

31.11. Indivior plc.

31.12. Lannett Company Inc.

31.13. BioDelivery Sciences International Inc.

31.14. Insys Therapeutics Inc.

31.15. Camurus AB

32. Global Addictions Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Addictions Therapeutics Market

34. Recent Developments In The Addictions Therapeutics Market

35. Addictions Therapeutics Market High Potential Countries, Segments and Strategies

35.1 Addictions Therapeutics Market In 2029 - Countries Offering Most New Opportunities

35.2 Addictions Therapeutics Market In 2029 - Segments Offering Most New Opportunities

35.3 Addictions Therapeutics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Addictions Therapeutics Market, Sub-Segmentation Of Buprenorphine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Addictions Therapeutics Market, Sub-Segmentation Of Naltrexone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Addictions Therapeutics Market, Sub-Segmentation Of Bupropion, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Addictions Therapeutics Market, Sub-Segmentation Of Disulfiram, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Addictions Therapeutics Market, Sub-Segmentation Of Nicotine Replacement Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Addictions Therapeutics Market, Sub-Segmentation Of Varenicline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Addictions Therapeutics Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Addictions Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Global Addictions Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Asia-Pacific, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Asia-Pacific, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: China, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: China, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: India, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: India, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Japan, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Japan, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Australia, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Australia, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Indonesia, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Indonesia, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: South Korea, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: South Korea, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Western Europe, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Western Europe, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: UK, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: UK, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Germany, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Germany, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: France, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: France, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Italy, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Italy, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Spain, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Spain, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Eastern Europe, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Eastern Europe, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Russia, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Russia, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: North America, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: North America, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: USA, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: USA, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Canada, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Canada, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: South America, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: South America, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Brazil, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Brazil, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Middle East, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Middle East, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Africa, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: Africa, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 83: Pfizer Inc. Financial Performance
  • Table 84: Novartis AG Financial Performance
  • Table 85: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Table 86: Mylan N.V. Financial Performance
  • Table 87: Bausch Health Companies Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Addictions Therapeutics Market, Sub-Segmentation Of Buprenorphine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Addictions Therapeutics Market, Sub-Segmentation Of Naltrexone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Addictions Therapeutics Market, Sub-Segmentation Of Bupropion, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Addictions Therapeutics Market, Sub-Segmentation Of Disulfiram, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Addictions Therapeutics Market, Sub-Segmentation Of Nicotine Replacement Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Addictions Therapeutics Market, Sub-Segmentation Of Varenicline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Addictions Therapeutics Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Addictions Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Global Addictions Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Asia-Pacific, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Asia-Pacific, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: China, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: China, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: India, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: India, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Japan, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Japan, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Australia, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Australia, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Indonesia, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Indonesia, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: South Korea, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: South Korea, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Western Europe, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Western Europe, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: UK, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: UK, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Germany, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Germany, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: France, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: France, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Italy, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Italy, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Spain, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Spain, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Eastern Europe, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Eastern Europe, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Russia, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Russia, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: North America, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: North America, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: USA, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: USA, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Canada, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Canada, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: South America, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: South America, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Brazil, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Brazil, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Middle East, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Middle East, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Africa, Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: Africa, Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 83: Pfizer Inc. Financial Performance
  • Figure 84: Novartis AG Financial Performance
  • Figure 85: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Figure 86: Mylan N.V. Financial Performance
  • Figure 87: Bausch Health Companies Inc. Financial Performance

$5.62 Billion Forecast for Liver Cancer Market by 2029, Backed by Demand and Innovation

Read More About $5.62 Billion Forecast for Liver Cancer Market by 2029, Backed by Demand and Innovation

Lupus Nephritis Market Valuation Expected To Reach $2.78 Billion By 2029, Growing At A Rate Of 7.5%

Read More About Lupus Nephritis Market Valuation Expected To Reach $2.78 Billion By 2029, Growing At A Rate Of 7.5%

Strong CAGR to Propel in the Malignant Mesothelioma Market and Beyond upto $3.32 Billion by 2029

Read More About Strong CAGR to Propel in the Malignant Mesothelioma Market and Beyond upto $3.32 Billion by 2029

Malignant Pleural Effusion Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Read More About Malignant Pleural Effusion Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Read More About Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Read More About Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Read More About Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Value Based Care Payment Market 2023 – By Model (Accountable Care Organization (ACO), Bundled Payments, Patient-Centered Medical Home (PCMH), Pay For Performance (P4P)), By Deployment Type (Cloud Based, On-Premise), By E...

View Report

Fertility Services Market 2023 – By Procedure (Assisted Reproductive Technology (Art), In-Vitro Fertilization, Artificial Insemination), By Service (Fresh Non-Donor, Frozen Non-Donor, Egg And Embryo Banking, Fresh Donor,...

View Report

Stone Mining And Quarrying Global Market Report 2020 - By Type (Dimension Stone Mining, Crushed Stone Mining), By Organization Size (large Enterprises, Small And Medium Enterprises), COVID-19 Impact...

View Report

Dimension Stone Mining Global Market Report 2020 - By Type (Marble, Granite, Limestone, Sandstone)...

View Report

Truck Transportation Global Market Report 2020 - By Type (General Freight Trucking, Specialized Freight Trucking Local General Freight Trucking, Long-Distance General Freight Trucking, Automobiles And Heavy Equipment, Bu...

View Report

Crushed Stone Mining Global Market Report 2020 - By Type (Limestone Mining, Granite Mining)...

View Report

Telehealth Market 2021 - By Type (Software, Services, Hardware), By Mode Of Delivery (Cloud-Based, On-Premise), By Application (Teleradiology, Telepsychiatry, Telepathology, Teledermatology, Telecardiology), By End-User ...

View Report

Robotic Surgery Services Global Market Report 2025 – By Component (Systems, Accessories, Services), By Application (General Surgery, Urological Surgery, Gynecological Surgery, Orthopaedics Surgery, Neurosurgery And Other...

View Report

Frequently Asked Questions

Addiction therapeutics refers to medication, treatment, and management of various forms of addiction to help individuals overcome substance use disorders (SUDs) and other forms of addiction. It involves group and individual therapy sessions to prevent substance misuse. For further insights on this market, request a sample here

The market major growth driver - Rising Alcohol Consumption Drives Growth In The Addiction Therapeutics Market. For further insights on this market, request a sample here

The addictions therapeutics market size has grown strongly in recent years. It will grow from $7.05 billion in 2024 to $7.46 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increased use of addictive substances such as alcohol, tobacco, and drugs, rising awareness and escalating prevalence of substance abuse disorders, legalization of marijuana in various states, increased funding and support for addiction treatment initiatives. The addictions therapeutics market size is expected to see strong growth in the next few years. It will grow to " $9.57 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to rising drug awareness campaigns, emergence of synthetic drugs and new psychoactive substances, changing lifestyles and stress factors, expanding rehabilitation facilities, integration of telehealth services in addiction treatment. Major trends in the forecast period include technological advancements in diagnostics, neuroscientific advances, partnerships and collaborations between pharmaceutical companies and other stakeholders to address addiction issues, innovative drug launch for addictions therapeutics. For further insights on this market, request a sample here

The addictions therapeuticsmarket covered in this report is segmented –
1) By Drug Type: Buprenorphine; Naltrexone; Bupropion; Disulfiram; Nicotine Replacement Products; Varenicline; Other Drugs
2) By Treatment Type: Opioid Addiction Treatment; Alcohol Addiction Treatment; Nicotine Addiction Treatment; Other Substance Addiction Treatment
3) By Treatment Center: Inpatient Treatment Center; Residential Treatment Center; Outpatient Treatment Center
4) By Distribution Channel: Hospital Pharmacies; Medical Stores; Other Distribution Channel
5) By Application: Public; Private; Government Subsegments:
1) By Buprenorphine: Subutex; Suboxone
2) By Naltrexone: Oral Naltrexone; Extended-Release Naltrexone (Vivitrol)
3) By Bupropion: Wellbutrin; Zyban
4) By Disulfiram: Antabuse
5) By Nicotine Replacement Products: Nicotine Patches; Nicotine Gum; Nicotine Inhalers; Nicotine Lozenges
6) By Varenicline: Chantix (Champix)
7) By Other Drugs: Acamprosate; Topiramate; Gabapentin For further insights on this market, request a sample here

North America was the largest region in the addictions therapeutics market in 2024. The regions covered in the addictions therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the addictions therapeutics market include Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Perrigo Company plc, Purdue Pharma L.P., Dr. Reddy's Laboratories Ltd., Cipla Inc., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Mallinckrodt Plc, Alkermes plc., Glenmark Pharmaceuticals Limited, Indivior plc., Lannett Company Inc., BioDelivery Sciences International Inc., Insys Therapeutics Inc., Camurus AB, Orexo AB, Elite Pharmaceuticals Inc., Braeburn Inc., Titan Pharmaceuticals Inc., BioCorRx Inc. . For further insights on this market, request a sample here.

Major trends in this market include Innovative Breakthroughs In Addiction Therapeutics Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Addictions Therapeutics Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top